Nitazoxanide
Renal and hepatic impairment. Pregnancy and lactation. Children <1 yr.
Giardiasis, Cryptosporidiosis
Hypersensitivity.
N/A
1-10% Headache (1%),Abdominal pain (8%),Diarrhea (2%),Nausea (3%),Chromaturia (2%),Vomiting (1%) <1% Increased ALT,Anorexia,Appetite increased,Creatinine increased,Diaphoresis,Dizziness,Eye discoloration (pale yellow),Fever,Flatulence,Infection,Malaise,Pruritus,Thinitis,Salivary glands enlarged,Urine discoloration
Nitazoxanide is an antiprotozoal agent. Both nitazoxanide and its active metabolite (tizoxanide) interfere with the pyruvate:ferredoxin 2-oxidoreductase (PFOR) enzyme-dependent electron transfer reaction which is essential to anaerobic metabolism in susceptible organisms.
May possibly interact with highly protein-bound drugs e.g. warfarin.
N/A
Oral Giardiasis; Cryptosporidiosis Adult: 500 mg every 12 hr for 3 days.
Oral Giardiasis; Cryptosporidiosis Child: 1-3 yr: 100 mg(5 ml) every 12 hr; 4-11 yr: 200 mg(10ml) every 12 hr; >12 yr: 500 mg every 12 hr. All doses to be taken for 3 days.
N/A
Should be taken with food.
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.